Trial · NCT03595397
Thoracic Epidural Analgesia in Multiple Traumatic Fracture Ribs
NCT03595397, Not applicable, Unknown, Assiut University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Thoracic Epidural Analgesia in Multiple Traumatic Fracture Ribs. Trials, record NCT03595397. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03595397
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Thoracic Epidural Analgesia in Multiple Traumatic Fracture Ribs
- NCT number
- NCT03595397
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Assiut University
- Conditions
- Thoracic Epidural Analgesia, Fracture Ribs
- Interventions
- Bupivacaine, Magnesium Sulfate, Fentanyl, Thoracic epidural
- First posted
- 2018-07-23
- Last updated
- 2018-07-23
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in Pain Scores (Visual Analogue pain scale) | 48 hours | Visual analog scale \[VAS\] is a measure of pain intensity. It is a continuous scale comprised of a horizontal or vertical scale usually 10 cm or 100 mm length. For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[on 100-mm scale\]. The pain visual analog scale is self completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. After the patient has marked, using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark. The scores can be from 0-100. A higher score indicates greater pain intensity. Based on the distribution of pain, the following cut points on the pain VAS have been recommended: No pain (0 -4 mm) Mild pain (5-44 mm) Moderate pain (45-74 mm) Severe pain (75-100 mm) |
| Secondary | Development of pulmonary complications: respiratory rate by breath per minute (need for mechanical ventilation) | 48 hours | By observing respiratory rate of patients using clinical assessment every 1 hour |
| Secondary | Assessment of parameters of adequate ventilation and oxygenation: PaO2/FIO2 ratio | 48 hours | by measuring O2 level in the blood using arterial blood gases every 3 hours |
| Secondary | Assessment of parameters of adequate ventilation and oxygenation: PaCO2 in mmHg | 48 hours | by measuring CO2 level in the blood using arterial blood gases every 3 hours |
| Secondary | Changes in heart rate (HR) by beats per minute | 48 hours | By monitoring patients heart rate every 1 hour |
| Secondary | changes in arterial blood pressure (ABP) by mmHg | 48 hours | By monitoring patients arterial blood pressure using non invasive arterial blood pressure monitoring every 1 hour |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03595397
GET https://conductscience.org/api/trials/v1/NCT03595397/registered